Nutramax re-signs Palmer, sponsors golf tour
EDGEWOOD, Md. — Nutramax Labs on Thursday announced the continuation of its partnership with Hall of Fame pitcher Jim Palmer, spokesman of the Cosamin joint health supplements in national and regional marketing campaigns and events.
"We are pleased to enter into our 11th year of partnership with Jim Palmer,” stated Troy Henderson, VP corporate operations and professional services at Nutramax. “Palmer continues to be an excellent [spokesman] for Cosamin joint health supplements because Cosamin is not just for athletes, but [also] for anyone who is active."
"Ten years ago, my orthopedic doctor recommended Cosamin for my joint pain,” Palmer said. “I’ve been using it ever since, and at 65, I’m still very active and doing the things I love most since retiring from Major League Baseball in 1985."
Palmer is scheduled to appear on behalf of Nutramax at the Professional Baseball Athletic Trainers Society meeting in Orlando, Fla., on Dec. 4, where he will discuss the importance of the NSF Certified for Sport designation on select batches of Cosamin ASU and Cosamin DS products, Nutramax stated.
Nutramax also recently announced its sponsorship of the 2011 Georgia PGA Senior Tour. Last year, Nutramax sponsored the Senior Tour Championship at the Legends at Chateau Elan, where the Cosamin ASU trophy was awarded to long-time Cosamin consumer DeWitt Weaver.
Prestige Brands names CFO
IRVINGTON, N.Y. — Prestige Brands Holdings on Thursday named Ron Lombardi its new CFO, effective Dec. 6. The position had been vacated by the retirement of Pete Anderson.
“[Lombardi] is a results-oriented financial professional whose extensive background in business development, acquisitions and divestitures, and debt and equity structuring will serve Prestige well as we move into our next phase of growth following our recent acquisition of Blacksmith Brands,” stated Matthew Mannelly, Prestige president and CEO.
Prior to joining Prestige, Lombardi served as CFO for Waterbury International Holdings, a private-equity-owned firm, in which he was responsible for all financial and business development activities, leading to the successful sale of that company.
CDC looks to reach at-risk groups during National Influenza Vaccination Week
ATLANTA — The Centers for Disease Control and Prevention has set aside the week of Dec. 5 to observe this season’s National Influenza Vaccination Week. The week-long emphasis on flu vaccination was established to highlight the importance of continuing influenza vaccination, as well as foster greater use of flu vaccine after the holiday season into January and beyond.
One of the many goals for NIVW is to engage at-risk audiences who are not yet vaccinated, are hesitant about vaccination or are unsure about where to get vaccinated. Each day of National Influenza Vaccination Week is designated to highlight the importance for certain groups — including families, older adults and people with such high-risk conditions as diabetes, asthma and heart problems — to get vaccinated.
However, the CDC for the first time is advising that everyone older than 6 months be vaccinated. “The new vaccination recommendation shows the importance of preventing the flu in everyone,” stated Anne Schuchat, assistant surgeon general of the U.S. Public Health Service and the CDC’s director of the National Center for Immunization and Respiratory Diseases. “People who do not get vaccinated are taking two risks: First, they are placing themselves at risk for the flu, including a potentially long and serious illness, and second, if they get sick, they are also placing their close contacts at risk for influenza.”
To date, approximately 160 million doses of the flu vaccine have been distributed nationwide.